Write in a clean editor, then format for BMC Endocrine Disorders in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
BMC Endocrine Disorders is a peer-reviewed journal published by BMC (BioMed Central), covering Diabetes, Cardiovascular Risks, and Lipoproteins, Thyroid Disorders and Treatments, Diabetes Management and Research. Over its lifetime it has published 2,725 papers, which have received 48,466 citations.
| Publisher | BMC (BioMed Central) |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. BMC Endocrine Disorders. 2023;12(3):45–58.
Formats any DOI in BMC Endocrine Disorders style. No sign-up. |
| Publishes research in | Diabetes, Cardiovascular Risks, and Lipoproteins Thyroid Disorders and Treatments Diabetes Management and Research Thyroid Cancer Diagnosis and Treatment Diabetes Management and Education |
| ISSN | 1472-6823 |
| Citation impact (2-yr) | 3.08 |
| h-index | 82 |
| i10-index | 1,308 |
| Article processing charge | $2,072 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Tehran University of Medical Sciences |
| Journal website | www.biomedcentral.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Given the increasing prevalence of diabetes and obesity worldwide, the deleterious effects of non-alcoholic fatty liver disease (NAFLD) are becoming a growing challenge for public health. NAFLD is the most common chronic liver disease in the Western world. NAFLD is closely associated with metabolic disorders, including central obesity, dyslipidaemia, hypertension, hyperglycaemia and persistent abnormalities of…
BACKGROUND: Insulin resistance has been associated with metabolic and hemodynamic alterations and higher cardio metabolic risk. There is great variability in the threshold homeostasis model assessment of insulin resistance (HOMA-IR) levels to define insulin resistance. The purpose of this study was to describe the influence of age and gender in the estimation of HOMA-IR optimal…
BACKGROUND: Traditional high volume aerobic exercise training reduces cardiovascular and metabolic disease risk but involves a substantial time commitment. Extremely low volume high-intensity interval training (HIT) has recently been demonstrated to produce improvements to aerobic function, but it is unknown whether HIT has the capacity to improve insulin action and hence glycemic control. METHODS: Sixteen…
BACKGROUND: Diabetes Mellitus is an increasingly prevalent chronic disease characterized by the body's inability to metabolize glucose. The objective of this study was to build an effective predictive model with high sensitivity and selectivity to better identify Canadian patients at risk of having Diabetes Mellitus based on patient demographic data and the laboratory results during…
BACKGROUND: In a previous pooled analysis of 12 double-blind clinical studies that included data on 6,139 patients with type 2 diabetes, treatment with sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, was shown to be generally well tolerated compared with treatment with control agents. As clinical development of sitagliptin continues, additional studies have been completed, and more…
